Canada’s healthcare services are the envy of many other countries because Canadian patients have access to the best healthcare professionals, infrastructure and facilities in the industry.
Despite this, not everyone in the community has their needs met, especially if they require immediate medical attention or are seeking alternative treatments that are considered traditional or outside of current means.
This is where organizations like Richmond Clinical Trials can step in and fill a critical need.
The company, which specializes in clinical research for the pharmaceutical industry, seeks patients to participate in studies to help medical professionals better understand the disease, its progression, and potential treatments.
The Richmond Clinical Trial is currently recruiting adults across the Lower Mainland who have been diagnosed with COPD (chronic obstructive pulmonary disease) and are at risk for cardiopulmonary events, as well as adults with type II diabetes who are prescribed metformin with or without an SGLT2 inhibitor. Applicants must undergo and pass a required screening process to ensure they meet specific study criteria. Selected participants will be expected to adhere to the study protocol and attend scheduled study visits.
Instead, there are many benefits to participating in a clinical trial.
First, many patients can receive the latest treatments before they become widely available, which is particularly beneficial for patients with conditions that have limited treatment options.
Patients also have the opportunity to learn more about their specific symptoms and possible treatments and to become more informed about medical decisions. Care is delivered in a timely and patient-centered manner.
Are there any risks?
While investigational products may have risks that are not immediately apparent, doctors and nurses in the Richmond clinical trial are closely monitoring the health of all subjects.
“As a nurse and research assistant at Richmond Clinical Trials, my responsibility is to ensure the safety of potential research study participants,” says Sarah Eftekar. “This includes comprehensively reviewing their medical history, lab results, and medications, as well as conducting detailed physical exams.”
“Participants’ safety is our top priority, and we will work closely with participants’ physicians to monitor and maintain their health throughout the duration of the study.”
Eftekar added that no one is forced to take part and that people can always schedule an interview to discuss the risks and benefits before deciding to participate.
Furthermore, participants are free to withdraw from the clinical trial at any time.
“People appreciate being able to easily ask nurses and doctors questions about their health and treatment options,” says Eftekar. “Building trust, being there for our participants, and promoting inclusivity are our priorities. We build strong relationships with our participants, and they look forward to visiting our office.”
In the future, the Richmond Clinical Trials will be conducting new studies into a variety of other diseases. Even if your disease is not currently being studied, please contact us if you are interested in participating in a study for any indication.
To see if participating in a study through Richmond Clinical Trials is the best option for you, visit the website at richmondclinicaltrials.com for more information or call 604-373-4954.
